Membranous glomerulonephritis: current status.
D000328:Adult; D000368:Aged; D000818:Animals; D000937:Antigen-Antibody Reactions; D001172:Arthritis, Rheumatoid / Q000150:complications; D001485:Basement Membrane / Q000473:pathology; D001706:Biopsy; D002648:Child; D003095:Collagen Diseases / Q000150:complications; D004195:Disease Models, Animal; D004847:Epithelial Cells; D005260:Female; D005368:Filariasis / Q000150:complications; D005455:Fluorescent Antibody Technique; D005921:Glomerulonephritis / Q000188:drug therapy / Q000209:etiology / Q000276:immunology / Q000473:pathology / Q000628:therapy; D006046:Gold / Q000627:therapeutic use; D006801:Humans; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007678:Kidney Glomerulus / Q000276:immunology / Q000473:pathology; D008288:Malaria / Q000150:complications; D008297:Male; D008628:Mercury / Q000627:therapeutic use; D008854:Microscopy, Electron; D008875:Middle Aged; D009404:Nephrotic Syndrome / Q000209:etiology; D011379:Prognosis; D011817:Rabbits; D012075:Remission, Spontaneous; D012082:Renal Veins; D013590:Syphilis, Congenital / Q000150:complications; D013592:Syphilis, Latent / Q000150:complications
D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D006046:Gold; D008628:Mercury